Featured Image
February 14 – 2024

Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

Funding News

Commit Biologics has received an Innobooster Grant of 5M DKK from the Innovation Fund Denmark (IFD) to support further development of the BiCE technology to fight cancer. This is the 2nd Innobooster Grant Commit Biologics receives from the Innovation Fund Denmark.

Read more about Innovation Fund Denmark.

Back to news

More news

Featured Image
February 14 – 2024

Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

Funding News
Commit Biologics has received an Innobooster Grant of 5M DKK from the Innovation Fund Denmark (IFD) to support further development of the BiCE technology to fight cancer. This is the 2nd Innobooster Grant Commit …
Featured Image
August 28 – 2023

Commit Biologics appoints Krishna Polu as Chief Executive Officer

News
Krishna Polu is appointed CEO of Commit Biologics. Krishna brings a wealth of operating experience to the team with a track record of pipeline advancement and drug approvals across multiple therapeutics areas. Most recently, …
Featured Image
June 28 – 2023

Publication describing the BiCE technology featured in Journal of Immunology

Publication Research Technology
A joint collaboration between researchers from Commit Biologics, Christian-Albrechts-University in Kiel and Aarhus University has led to a better understanding of the complement system. The complement system plays a vital role in immune defenses. …

For inquiries please contact us
at info@commitbio.com

Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark

+45 3049 7099
LinkedIn

© 2022 Commit Biologics. All rights reserved.

CB_Brandmark_Light-Green